查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886568

對比增強超音波市場－全球產業規模、佔有率、趨勢、機會和預測，依產品、類型、最終用途、地區和競爭格局分類，2020-2030年預測

Contrast Enhanced Ultrasound Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By End use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球對比增強超音波市場規模為22.7億美元，預計到2030年將以4.65%的複合年成長率成長至29.8億美元。對比增強超音波（CEUS）是一種診斷影像技術，它利用靜脈注射的充氣微泡來增強標準醫學超音波檢查中血流和組織血管的顯像效果。此技術透過突顯器官和病灶中的血管模式來提高診斷精度，通常能提供比傳統超音波更清晰的影像。

市場概覽
預測期 2026-2030
市場規模：2024年 22.7億美元
市場規模：2030年 29.8億美元
複合年成長率：2025-2030年 4.65%
成長最快的細分市場 非標靶
最大的市場 北美洲

主要市場促進因素

全球慢性疾病負擔日益加重，是對比增強超音波市場的重要促進因素。心血管疾病、癌症和肝臟疾病等都需要準確且頻繁的診斷影像，以便早期發現、分期和監測治療。

主要市場挑戰

全球熟練超音波醫師的短缺對對比增強超音波市場的成長構成了重大挑戰。對比增強超音波檢查操作複雜，需要專業技能才能準確操作、擷取和解讀影像。

主要市場趨勢

人工智慧的整合顯著提升了對比增強超音波技術，提高了影像分析和診斷能力。人工智慧演算法能夠自動完成分割、異常檢測並最佳化工作流程，從而提高準確性和效率，並有可能減少人為錯誤。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球對比增強超音波市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品分類（設備、顯影劑）
    • 按類型（非定向、定向）
    • 依最終用途（醫院、診所、門診診斷中心）分類
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美對比增強超音波市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲對比增強超音波市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區對比增強超音波市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲對比增強超音波市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲對比增強超音波市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球對比增強超音波市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Lantheus Holdings, Inc.
  • General Electric Company
  • Siemens Healthineers Company
  • nanoPET Pharma GmbH
  • ESAOTE SPA
  • GE HealthCare Technologies, Inc.
  • Koninklijke Philips NV
  • Leriva SA

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22212

The Global Contrast Enhanced Ultrasound Market, valued at USD 2.27 Billion in 2024, is projected to experience a CAGR of 4.65% to reach USD 2.98 Billion by 2030. Contrast-enhanced ultrasound (CEUS) is a diagnostic imaging modality that utilizes intravenously administered, gas-filled microbubbles to enhance the visualization of blood flow and tissue vascularization during standard medical sonography. This technique improves diagnostic precision by accentuating vascular patterns in organs and lesions, often providing clearer images than conventional ultrasound.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.27 Billion
Market Size 2030USD 2.98 Billion
CAGR 2025-20304.65%
Fastest Growing SegmentNon-Targeted
Largest MarketNorth America

Key Market Drivers

The rising global burden of chronic diseases is a significant market driver for Contrast Enhanced Ultrasound. Conditions like cardiovascular disease, cancer, and hepatic disorders require accurate and frequent diagnostic imaging for early detection, staging, and monitoring treatment. CEUS provides a non-invasive, radiation-free method to precisely assess tissue perfusion and vascularity, which is crucial for characterizing lesions and evaluating organ function. This capability assists clinicians in making timely patient management decisions.

Key Market Challenges

The global scarcity of skilled sonographers poses a significant challenge to the growth of the Contrast Enhanced Ultrasound market. The sophisticated nature of CEUS procedures requires specialized expertise for accurate operation, image acquisition, and interpretation. Without an adequate pool of trained professionals, healthcare facilities face limitations in adopting and fully utilizing this advanced imaging modality, regardless of its diagnostic benefits.

Key Market Trends

AI integration is significantly enhancing contrast-enhanced ultrasound by improving image analysis and diagnostic capabilities. Artificial intelligence algorithms automate segmentation, anomaly detection, and optimize workflow, thereby improving accuracy and efficiency and potentially reducing human error. This technological advance enables faster interpretation of complex images and supports early disease detection, leading to improved patient outcomes. According to Medical Device Network, in July 2023, UltraSight received FDA approval for its AI-based cardiac ultrasound guidance technology, enabling medical professionals without prior sonography experience to capture diagnostic-quality images at the point of care.

Key Market Players

  • Lantheus Holdings, Inc.
  • General Electric Company
  • Siemens Healthineers Company
  • nanoPET Pharma GmbH
  • ESAOTE SPA
  • GE HealthCare Technologies, Inc.
  • Koninklijke Philips N.V.
  • Leriva SA

Report Scope:

In this report, the Global Contrast Enhanced Ultrasound Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contrast Enhanced Ultrasound Market, By Product:

  • Equipment
  • Contrast Agents

Contrast Enhanced Ultrasound Market, By Type:

  • Non-targeted
  • Targeted

Contrast Enhanced Ultrasound Market, By End use:

  • Hospitals
  • Clinics
  • Ambulatory Diagnostic Centers

Contrast Enhanced Ultrasound Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Contrast Enhanced Ultrasound Market.

Available Customizations:

Global Contrast Enhanced Ultrasound Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contrast Enhanced Ultrasound Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Equipment, Contrast Agents)
    • 5.2.2. By Type (Non-targeted, Targeted)
    • 5.2.3. By End use (Hospitals, Clinics, Ambulatory Diagnostic Centers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Contrast Enhanced Ultrasound Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Type
    • 6.2.3. By End use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Contrast Enhanced Ultrasound Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By End use
    • 6.3.2. Canada Contrast Enhanced Ultrasound Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By End use
    • 6.3.3. Mexico Contrast Enhanced Ultrasound Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By End use

7. Europe Contrast Enhanced Ultrasound Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Type
    • 7.2.3. By End use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Contrast Enhanced Ultrasound Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By End use
    • 7.3.2. France Contrast Enhanced Ultrasound Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By End use
    • 7.3.3. United Kingdom Contrast Enhanced Ultrasound Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By End use
    • 7.3.4. Italy Contrast Enhanced Ultrasound Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By End use
    • 7.3.5. Spain Contrast Enhanced Ultrasound Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By End use

8. Asia Pacific Contrast Enhanced Ultrasound Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By End use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Contrast Enhanced Ultrasound Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By End use
    • 8.3.2. India Contrast Enhanced Ultrasound Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By End use
    • 8.3.3. Japan Contrast Enhanced Ultrasound Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By End use
    • 8.3.4. South Korea Contrast Enhanced Ultrasound Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By End use
    • 8.3.5. Australia Contrast Enhanced Ultrasound Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By End use

9. Middle East & Africa Contrast Enhanced Ultrasound Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By End use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Contrast Enhanced Ultrasound Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By End use
    • 9.3.2. UAE Contrast Enhanced Ultrasound Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By End use
    • 9.3.3. South Africa Contrast Enhanced Ultrasound Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By End use

10. South America Contrast Enhanced Ultrasound Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Type
    • 10.2.3. By End use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Contrast Enhanced Ultrasound Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By End use
    • 10.3.2. Colombia Contrast Enhanced Ultrasound Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By End use
    • 10.3.3. Argentina Contrast Enhanced Ultrasound Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By End use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Contrast Enhanced Ultrasound Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Lantheus Holdings, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. General Electric Company
  • 15.3. Siemens Healthineers Company
  • 15.4. nanoPET Pharma GmbH
  • 15.5. ESAOTE SPA
  • 15.6. GE HealthCare Technologies, Inc.
  • 15.7. Koninklijke Philips N.V.
  • 15.8. Leriva SA

16. Strategic Recommendations

17. About Us & Disclaimer